Get all premium features to the best stock analysis tool

Finranks

Finranks

Company

  • About us

Contact us

  • [email protected]

Follow us

  • Instagram
  • Telegram
  • LinkedIn

All rights reserved.

Privacy PolicyTerms of Conditions
  • Home
  • Markets
  • Screener
  • News
  • About
  1. Home
  2. SIGA
S

SIGA Technologies, Inc. (SIGA)

NGM – Real Time Price. Currency in USD

5.30

+0.34 (6.85%)

At close: Mar 27, 2026, 4:00 PM EDT

5.24

-0.06 (-1.13%)

After-hours: Mar 27, 2026, 7:01 PM EDT

  • Summary
  • News
  • Chart
  • Financial
  • Dividends
  • Forecast
  • Ownership
  • Profile
Why Are Siga Technologies Shares Trading Higher?
27.03.2026

Why Are Siga Technologies Shares Trading Higher?

Siga's board of directors declared a special cash dividend of $0.60 per share on the company's common stock. The amount of this dividend is consistent with the special dividend declared last April.

SIGA Declares Special Cash Dividend of $0.60 Per Share
26.03.2026

SIGA Declares Special Cash Dividend of $0.60 Per Share

NEW YORK, March 26, 2026 (GLOBE NEWSWIRE) -- SIGA Technologies, Inc. (SIGA) (Nasdaq: SIGA), a commercial-stage pharmaceutical company, today announced that its board of directors declared a special cash dividend of $0.60 per share on the company's common stock. The amount of this dividend is consistent with the level of the special dividend declared in April 2025. The dividend is payable on April 23, 2026, to shareholders of record at the close of business on April 7, 2026.

SIGA Technologies, Inc. (SIGA) Q4 2025 Earnings Call Transcript
10.03.2026

SIGA Technologies, Inc. (SIGA) Q4 2025 Earnings Call Transcript

SIGA Technologies, Inc. (SIGA) Q4 2025 Earnings Call Transcript

SIGA Reports Financial Results for Three and Twelve Months Ended December 31, 2025 and Provides Business Update
10.03.2026

SIGA Reports Financial Results for Three and Twelve Months Ended December 31, 2025 and Provides Business Update

NEW YORK, March 10, 2026 (GLOBE NEWSWIRE) -- SIGA Technologies, Inc. (SIGA) (Nasdaq: SIGA), a commercial-stage pharmaceutical company, today reported financial results for the three and twelve months ended December 31, 2025.

SIGA to Host Business Update Call on March 10, 2026, Following Release of 2025 Financial Results
03.03.2026

SIGA to Host Business Update Call on March 10, 2026, Following Release of 2025 Financial Results

NEW YORK, March 03, 2026 (GLOBE NEWSWIRE) -- SIGA Technologies, Inc. (SIGA) (Nasdaq: SIGA), a commercial-stage pharmaceutical company, today announced that management will host a webcast and conference call to provide a business update at 4:30 P.M. ET on Tuesday, March 10, 2026.

SIGA Technologies, Inc. (SIGA) Q3 2025 Earnings Call Transcript
07.11.2025

SIGA Technologies, Inc. (SIGA) Q3 2025 Earnings Call Transcript

SIGA Technologies, Inc. ( SIGA ) Q3 2025 Earnings Call November 6, 2025 4:30 PM EST Company Participants Diem Nguyen - CEO & Director Daniel Luckshire - Executive VP, CFO & Secretary Conference Call Participants Jyoti Prakash - Edison Investment Research Limited Presentation Operator Welcome to the SIGA Business Update Call. Before we turn the call over to SIGA management, please note that any forward-looking statements made during this call are based on management's current expectations and observations and are subject to risks and uncertainties that could cause actual results to differ from the forward-looking statements.

SIGA Reports Financial Results for Three and Nine Months Ended September 30, 2025
06.11.2025

SIGA Reports Financial Results for Three and Nine Months Ended September 30, 2025

NEW YORK, Nov. 06, 2025 (GLOBE NEWSWIRE) -- SIGA Technologies, Inc. (SIGA) (Nasdaq: SIGA), a commercial-stage pharmaceutical company, today reported financial results for the three and nine months ended September 30, 2025. “We continue to advance SIGA's key priorities while generating $86 million in product revenues and $33 million in pre-tax operating income for the first nine months of 2025," stated Diem Nguyen, Chief Executive Officer.

Videos

No Data

There is no data to display

Press releases

SIGA Declares Special Cash Dividend of $0.60 Per Share
26.03.2026

SIGA Declares Special Cash Dividend of $0.60 Per Share

NEW YORK, March 26, 2026 (GLOBE NEWSWIRE) -- SIGA Technologies, Inc. (SIGA) (Nasdaq: SIGA), a commercial-stage pharmaceutical company, today announced that its board of directors declared a special cash dividend of $0.60 per share on the company's common stock. The amount of this dividend is consistent with the level of the special dividend declared in April 2025. The dividend is payable on April 23, 2026, to shareholders of record at the close of business on April 7, 2026.

SIGA Reports Financial Results for Three and Twelve Months Ended December 31, 2025 and Provides Business Update
10.03.2026

SIGA Reports Financial Results for Three and Twelve Months Ended December 31, 2025 and Provides Business Update

NEW YORK, March 10, 2026 (GLOBE NEWSWIRE) -- SIGA Technologies, Inc. (SIGA) (Nasdaq: SIGA), a commercial-stage pharmaceutical company, today reported financial results for the three and twelve months ended December 31, 2025.

SIGA to Host Business Update Call on March 10, 2026, Following Release of 2025 Financial Results
03.03.2026

SIGA to Host Business Update Call on March 10, 2026, Following Release of 2025 Financial Results

NEW YORK, March 03, 2026 (GLOBE NEWSWIRE) -- SIGA Technologies, Inc. (SIGA) (Nasdaq: SIGA), a commercial-stage pharmaceutical company, today announced that management will host a webcast and conference call to provide a business update at 4:30 P.M. ET on Tuesday, March 10, 2026.

SIGA Reports Financial Results for Three and Nine Months Ended September 30, 2025
06.11.2025

SIGA Reports Financial Results for Three and Nine Months Ended September 30, 2025

NEW YORK, Nov. 06, 2025 (GLOBE NEWSWIRE) -- SIGA Technologies, Inc. (SIGA) (Nasdaq: SIGA), a commercial-stage pharmaceutical company, today reported financial results for the three and nine months ended September 30, 2025. “We continue to advance SIGA's key priorities while generating $86 million in product revenues and $33 million in pre-tax operating income for the first nine months of 2025," stated Diem Nguyen, Chief Executive Officer.